Boulding Mark Elliott sold PTCT
January 7, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 11 shares of PTC Therapeutics, Inc. at $78.98 per share, a transaction worth $868.78. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
11
Price
$78.98
Total value
$868.78
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 7, 2026
Filing dateJanuary 8, 2026
Shares owned after117,659
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.